Log in
EdiTy Therapeutics
Contact
Sharon is an experienced biochemist and renowned oligo nucleotides expert. At QBI, she headed the entire planning of pre-clinical studies the pre-clinical siRNA pipeline, including in vitro and in vivo trials.
Links
View in org chart
Michal Golan-Mashiach
Co-Founder & CEO
Sharon Avkin Nachum
VP, Technology
Yoav Manaster
Co-Founder
Ofer Levy
VP, R&D
Assaf Marcus
VP, Translational Science
+ 3 more
5 members
Current role
VP, Technology at Utility Associates
VP, Technology at Rho
VP, Technology at Silicon Integration Initiative
VP, Technology at SMT
VP, Technology at SunTec India